Market Tracker

02/05 5:16pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.80
Delayed Data
As of Feb 05
 -0.02 / -2.44%
Today’s Change
0.79
Today|||52-Week Range
2.50
-39.85%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.82
Today’s open0.81
Day’s range0.80 - 0.85
Volume558,208
Average volume (3 months)633,740
Market cap$124.6M
Dividend yield--
Data as of 4:06pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp-0.07-6.36%
MNOVMediciNova Inc-0.14-3.26%
ECYTEndocyte Inc-0.16-5.03%
CORICorium International...-0.15-2.56%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts